Atossa Therapeutics, Inc. Common Stock
$2.42
$0.05 (+2.11%)
$2.39Day Range$2.48
Key Statistics
Market Cap
$23.65M
Shares Outstanding
10.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Nov 8, 2012
Round Lot
100
Locale
US
Trading Data
Day Open
$2.39
Day High
$2.48
Day Low
$2.39
Volume
45.8K
VWAP
$2.43
Prev Close
$2.37
Transactions
--
Acc. Volume
--
About Atossa Therapeutics, Inc. Common Stock
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
PHARMACEUTICAL PREPARATIONSSIC 283414 employees1448 NW MARKET STREET, SEATTLE, WA, 98107206.588.0256IPO Nov 8, 2012US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001488039
- Composite FIGI
- BBG002NCD8C8
- Share Class FIGI
- BBG002NCD954
- Ticker Root
- ATOS
- SIC Code
- 2834
About Atossa Therapeutics, Inc. Common Stock (ATOS) Stock
Atossa Therapeutics, Inc. Common Stock (ATOS) closed the 2026-09-16 session at $2.42, up 2.11% versus the previous close (+0.05). The stock opened at $2.39 and traded between $2.39 and $2.48 during that session. Session trading volume was 46K shares. The volume-weighted average price (VWAP) is $2.43.
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
Atossa Therapeutics, Inc. Common Stock has a market capitalization of $23.7 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. ATOS is listed on the XNAS exchange. The company employs approximately 14 people. Atossa Therapeutics, Inc. Common Stock is headquartered in SEATTLE, WA. The recorded listing date is 2012-11-08.
On this page you can find market ATOS stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.